$GDRX News

GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs

GoodRx Launches Its $14.99 Per Month Subscription Service, GoodRx Companion

GoodRx: Evident Stabilization, But GLP-1 Dependence Is A Risk (Upgrade)

The 5 Most Interesting Analyst Questions From GoodRx’s Q1 Earnings Call

GoodRx Holdings' (NASDAQ:GDRX) Soft Earnings Are Actually Better Than They Appear

Jim Cramer on GoodRx: “I’m Going to Grant You That Spec”

Citigroup Maintains Buy on GoodRx Holdings, Raises Price Target to $4

TD Cowen Maintains Buy on GoodRx Holdings, Raises Price Target to $4

GoodRx (GDRX) Q1 2026 Earnings Call Transcript

GoodRx Holdings, Inc. (GDRX) Q1 2026 Earnings Call Transcript

GoodRx Q1 Earnings Call Highlights

GoodRx Holdings, Inc. Q1 2026 Earnings Call Summary

GoodRx (GDRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

GoodRx (NASDAQ:GDRX) Beats Q1 CY2026 Sales Expectations

GoodRx Reports First Quarter 2026 Results

GoodRx Holdings Raises FY2026 Sales Guidance from $750.000M-$780.000M to $765.000M-$785.000M vs $764.443M Est

GoodRx Holdings Q1 Adj. EPS $0.07, Inline, Sales $194.006M Beat $185.137M Estimate

GoodRx Says New Higher Dose Wegovy HD Injection 7.2 Mg Is Now Available To Eligible Self-Pay Patients On GoodRx At $399 Per Month

3 Promising Penny Stocks With Market Caps Under $2B

2 Small-Cap Stocks with Competitive Advantages and 1 That Underwhelm